The opioid manufacturer's sales team has targeted major opioid prescribers for their marketing efforts



[ad_1]

NORMAN – Representatives of the opioid manufacturer Johnson & Johnson have targeted doctors who frequently prescribe opioids, according to a testimony in the Cleveland court case, where Johnson & Johnson and its affiliates are accused of selling opioids. contributing to an opioid epidemic that has resulted in thousands of overdose deaths and addictions in Oklahoma.

Oklahoma Attorney General Mike Hunter has accused drug companies of creating a public nuisance. He announced his intention to ask a judge to order pharmaceutical companies to pay billions of dollars to alleviate the problem.

In addition to targeting leading prescribers for sales calls, Johnson & Johnson has given some of them tens of thousands of dollars a year to talk to other doctors about pain management at training seminars. continuous and promotional activities sponsored by the pharmaceutical company, revealed Monday's testimony.

Kimberly Deem-Eshleman, Designated Representative of Johnson & Johnson, described the sales efforts and the Expression Activities as educational activities and said it made sense to select prestigious prescribers for the activities of the company. Oral expression, because they are the ones who know the best about drugs. .

Deem-Eshleman stated that the pharmaceutical company had no control over the content of what was being taught during continuing medical education courses.

Johnson & Johnson has also donated hundreds of thousands of dollars to several advocacy groups advocating for increased use of opioids to treat a wider variety of pain than cancer and end-of-life pain.

Johnson & Johnson has even launched a sales initiative in which sales representatives have consulted with doctors before the spring break to extol the benefits of their Opiod medications in treating spring breakages, sprains, strains and pains. in the lower back, according to testimony Friday.

The testimony continues Monday afternoon. It is the fifth day of a trial that is expected to last about two months.

[ad_2]

Source link